Eslizepine 400 mg 20 tablets

Eslizepine 400 mg 20 tablets

Composition (per 1 tablet): 

Eslicarbazepine acetate – 400 mg. Excipients: microcrystalline cellulose, povidone, magnesium stearate, croscarmellose sodium, silicon dioxide, lactose. 

Description: 

Eslizepin is an antiepileptic medication used to control partial and generalized seizures. The active ingredient, eslicarbazepine acetate, stabilizes neuronal activity, reducing the risk of epileptic episodes and improving patients’ quality of life. 

Properties: 

Reduces frequency and severity of seizures. 
Stabilizes nerve cell function and decreases excitability. 
Suitable for monotherapy and adjunctive epilepsy treatment. 
Long-acting formulation allows once-daily dosing. 
Well-tolerated during long-term use. 

Indications for Use: 

Partial seizures with or without secondary generalization. 
Generalized tonic-clonic seizures. 
Combination therapy in epilepsy when other medications are insufficient. 

Method of Application: 

Adults and adolescents over 12 years: initial dose is typically 400 mg once daily, then may be increased to 800–1200 mg daily depending on response and tolerance. 
Swallow tablets with sufficient water, regardless of meals. 
Treatment duration should be determined individually by a healthcare professional. 

Storage Conditions: 

Store at +5°C…+25°C, in a dry place, protected from light and moisture. 

Packaging: 

Carton box containing 20 tablets.